Wells Fargo’s Vir Biotechnology VIR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$372K Sell
41,561
-63,851
-61% -$509K ﹤0.01% 4314
2025
Q4
$636K Buy
105,412
+29,967
+40% +$178K ﹤0.01% 4309
2025
Q3
$431K Buy
75,445
+13,278
+21% +$67.9K ﹤0.01% 4410
2025
Q2
$313K Buy
62,167
+5,735
+10% +$30.7K ﹤0.01% 4471
2025
Q1
$366K Buy
56,432
+3,771
+7% +$33.5K ﹤0.01% 4294
2024
Q4
$387K Sell
52,661
-199,096
-79% -$1.57M ﹤0.01% 4353
2024
Q3
$1.89M Buy
251,757
+209,341
+494% +$1.82M ﹤0.01% 3095
2024
Q2
$378K Buy
42,416
+12,620
+42% +$121K ﹤0.01% 4088
2024
Q1
$302K Buy
29,796
+3,771
+14% +$38.4K ﹤0.01% 4217
2023
Q4
$262K Sell
26,025
-90,443
-78% -$826K ﹤0.01% 4299
2023
Q3
$1.09M Buy
116,468
+26,028
+29% +$371K ﹤0.01% 3267
2023
Q2
$2.22M Buy
90,440
+20,313
+29% +$510K ﹤0.01% 2823
2023
Q1
$1.63M Buy
70,127
+63,824
+1,013% +$1.63M ﹤0.01% 3033
2022
Q4
$160K Sell
6,303
-5,060
-45% -$124K ﹤0.01% 4295
2022
Q3
$219K Sell
11,363
-1,385
-11% -$35.2K ﹤0.01% 4195
2022
Q2
$325K Sell
12,748
-29,471
-70% -$688K ﹤0.01% 4008
2022
Q1
$1.09M Sell
42,219
-17,963
-30% -$533K ﹤0.01% 3815
2021
Q4
$2.52M Sell
60,182
-377
-0.6% -$14.8K ﹤0.01% 3248
2021
Q3
$2.63M Buy
60,559
+42,761
+240% +$1.85M ﹤0.01% 3435
2021
Q2
$842K Sell
17,798
-4,711
-21% -$214K ﹤0.01% 4320
2021
Q1
$1.15M Sell
22,509
-77,602
-78% -$4.18M ﹤0.01% 4149
2020
Q4
$2.68M Buy
100,111
+58,771
+142% +$1.91M ﹤0.01% 3280
2020
Q3
$1.42M Sell
41,340
-26,294
-39% -$1.13M ﹤0.01% 3598
2020
Q2
$2.77M Buy
67,634
+55,674
+466% +$1.87M ﹤0.01% 3007
2020
Q1
$410K Buy
11,960
+11,373
+1,937% +$306K ﹤0.01% 4187
2019
Q4
$7K Buy
+587
New +$7.86K ﹤0.01% 5982

Other funds holding VIR